Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
LGALS1 elevation
i
Other names:
LGALS1, Galectin 1, GBP, Lectin, Galactoside-Binding, Soluble, 1, Beta-Galactoside-Binding Lectin L-14-I, Putative MAPK-Activating Protein PM12, 14 KDa Laminin-Binding Protein, Lactose-Binding Lectin 1, S-Lac Lectin 1, 14 KDa Lectin, Galectin-1, Galaptin, HLBP14, Gal-1, HBL, HPL, Epididymis Secretory Sperm Binding Protein, Beta-Galactoside-Binding Protein 14kDa, Lectin Galactoside-Binding Soluble 1, GAL 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3956
Related biomarkers:
Expression
‹
LGALS1 overexpression + LAG3 overexpression (2)
LGALS1 underexpression (1)
LGALS1 overexpression + LAG3 overexpression (2)
LGALS1 underexpression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
LGALS1 elevation
Esophageal Squamous Cell Carcinoma
LGALS1 elevation
Esophageal Squamous Cell Carcinoma
toripalimab-tpzi
Sensitive: C3 – Early Trials
toripalimab-tpzi
Sensitive
:
C3
toripalimab-tpzi
Sensitive: C3 – Early Trials
toripalimab-tpzi
Sensitive
:
C3
LGALS1 elevation
Pancreatic Ductal Adenocarcinoma
LGALS1 elevation
Pancreatic Ductal Adenocarcinoma
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
LGALS1 elevation
Pancreatic Ductal Adenocarcinoma
LGALS1 elevation
Pancreatic Ductal Adenocarcinoma
nivolumab + ipilimumab
Sensitive: C3 – Early Trials
nivolumab + ipilimumab
Sensitive
:
C3
nivolumab + ipilimumab
Sensitive: C3 – Early Trials
nivolumab + ipilimumab
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.